<International Circulation>:Do you think is a need for more clinical trials in China to answer some of these questions in a Chinese population?

Prof. Marco: Yes， we believe that there is a need for trials or registries dedicated to the Chinese population in order to understand if we are treating the same disease， and if the evolution of the disease is the same in China and Europe. As a result of these trials we then may have to change treatment methods according to the results of these trials.

上一页  [1]  [2]  [3]  [4]  下一页